E. Dragunsky

发表

Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.

J. Sampson, H. Ochiai, M. Gromeier, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization

R. Belshe, M. Laassri, K. Chumakov, 2005, Journal of Clinical Microbiology.

Determination of poliovirus-specific IgA in saliva by ELISA tests.

K. Chumakov, E. Dragunsky, A. Ivanov, 2005, Journal of virological methods.

Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.

E. Dragunsky, I. Levenbook, Y. Pervikovc, 2000, Vaccine.

RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence

K. Chumakov, E. Dragunsky, I. Levenbook, 1992, Journal of virology.

Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.

K. Chumakov, E. Dragunsky, G. Rezapkin, 1999, Virus research.

Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.

K. Chumakov, E. Dragunsky, G. Rezapkin, 1998, Virology.

Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived polioviruses

Majid Laassri, Konstantin Chumakov, V. Agol, 2003, Proceedings of the National Academy of Sciences of the United States of America.

ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines

E. Dragunsky, A. Ivanov, 2005, Expert review of vaccines.

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

R. Purcell, K. Chumakov, E. Dragunsky, 2011, Journal of Virology.

1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.

K. Chumakov, E. Dragunsky, A. Ivanov, 2006, The Journal of infectious diseases.

Repertoire of antibodies against type 1 poliovirus in human sera.

K. Chumakov, E. Dragunsky, G. Rezapkin, 2010, Journal of virological methods.

Immunogenicity of Inactivated Polio Vaccine with Concurrent Antiviral V-073 Administration in Mice

K. Chumakov, E. Dragunsky, M. Collett, 2011, Clinical and Vaccine Immunology.

Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.

L. Fan, K. Chumakov, E. Dragunsky, 1999, Virology.

Experimental evaluation of antitoxic protective effect of new cholera vaccines in mice.

H. D. Hochstein, E. Dragunsky, I. Levenbook, 1992, Vaccine.

Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis

S. Samal, G. Belov, M. Laassri, 2018, Journal of Virology.

Genetic stability and mutant selection in Sabin 2 strain of oral poliovirus vaccine grown under different cell culture conditions.

Z. Lu, K. Chumakov, E. Dragunsky, 1995, Virology.

Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.

A. Ivshina, K. Chumakov, E. Dragunsky, 2004, The Journal of infectious diseases.

Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.

Z. Lu, K. Chumakov, E. Dragunsky, 1994, Virology.

Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication

A. Gudkov, R. Wek, K. Chumakov, 2008, PloS one.

Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV).

K. Chumakov, E. Dragunsky, G. Rezapkin, 2005, Biologicals : journal of the International Association of Biological Standardization.

A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.

T. Nomura, E. Dragunsky, K. Hioki, 1996, Biologicals : journal of the International Association of Biological Standardization.

Morphologic evaluation of the pathogenesis of bacterial enteric infections.

E. Dragunsky, Y. Polotsky, T. Khavkin, 1994, Critical reviews in microbiology.

MicroRNAs as potential biomarkers for VERO cell tumorigenicity.

K. Peden, E. Dragunsky, K. Chumakov, 2014, Vaccine.

Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.

K. Chumakov, E. Dragunsky, S. Abe, 2006, The Journal of infectious diseases.

Inactivated vaccines based on alternatives to wild-type seed virus.

T. Nomura, A. Ivshina, M. Gromeier, 2001, Developments in biologicals.

Monkey neurovirulence test for live mumps vaccine.

P. Snoy, O. Maximova, E. Dragunsky, 1996, Biologicals : journal of the International Association of Biological Standardization.

New Small-Molecule Inhibitors Effectively Blocking Picornavirus Replication

L. Isaacs, G. Belov, K. Chumakov, 2014, Journal of Virology.

Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.

K. Chumakov, E. Dragunsky, O. Mirochnitchenko, 2015, The Journal of infectious diseases.

A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses.

R. Purcell, K. Chumakov, E. Dragunsky, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

In vitro characterization of Salmonella typhi mutant strains for live oral vaccines.

H. D. Hochstein, E. Dragunsky, I. Levenbook, 1990, Vaccine.

Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.

K. Chumakov, E. Dragunsky, G. Rezapkin, 1995, Virology.

Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.

E. Dragunsky, I. Levenbook, R. Taffs, 1993, Biologicals : journal of the International Association of Biological Standardization.

Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge.

E. Dragunsky, I. Levenbook, Y. Chernokhvostova, 1997, The Journal of infectious diseases.

Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.

Takeshi Kurata, Tatsuji Nomura, A. Heath, 2003, Bulletin of the World Health Organization.

Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937.

E. Dragunsky, I. Levenbook, S. Vargo, 1989, Journal of biological standardization.

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

R. Purcell, K. Chumakov, E. Dragunsky, 2011, Journal of Virology.

Poliovirus-Binding Inhibition ELISA for Evaluation of Immune Response to Oral Poliovirus Vaccine: A Possible Alternative to the Neutralization Test

K. Chumakov, E. Dragunsky, O. Ivanova, 2005, Human vaccines.